Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Scinai Immunotherapeutics's enterprise value was $247.41K on Nov 11, 2026, against $14.61M a year earlier. Over the last 5 years it ranged from $34.23K to $289.56M, with a median of $24.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $247.41K | -97.5% |
| 2025 | Dec 31, 2025 | $9.79M | -60.7% |
| 2024 | Dec 31, 2024 | $24.93M | +76.4% |
| 2023 | Dec 29, 2023 | $14.14M | -53.6% |
| 2022 | Dec 30, 2022 | $30.49M | -87.8% |
| 2021 | Dec 31, 2021 | $249.68M | +20.7% |
| 2020 | Dec 31, 2020 | $206.93M | -65.9% |
| 2019 | Dec 31, 2019 | $607.15M | +177.1% |
| 2018 | Dec 31, 2018 | $219.14M | +24.2% |
| 2017 | Dec 29, 2017 | $176.50M | +99.7% |
| 2016 | Dec 30, 2016 | $88.38M | – |
See a number that looks wrong?